Mirae Asset Global Investments Co. Ltd. Buys 15,201 Shares of Danaher Corporation (NYSE:DHR)

Mirae Asset Global Investments Co. Ltd. increased its position in shares of Danaher Corporation (NYSE:DHR) by 44.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,214 shares of the conglomerate’s stock after buying an additional 15,201 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Danaher Corporation were worth $4,209,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. Lee Danner & Bass Inc. boosted its stake in Danaher Corporation by 0.4% in the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after buying an additional 10 shares during the period. Rehmann Capital Advisory Group boosted its stake in Danaher Corporation by 0.6% in the first quarter. Rehmann Capital Advisory Group now owns 2,959 shares of the conglomerate’s stock worth $253,000 after buying an additional 19 shares during the period. Alpha Windward LLC boosted its stake in Danaher Corporation by 0.8% in the first quarter. Alpha Windward LLC now owns 2,605 shares of the conglomerate’s stock worth $223,000 after buying an additional 21 shares during the period. Assetmark Inc. boosted its stake in Danaher Corporation by 0.5% in the first quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock worth $566,000 after buying an additional 30 shares during the period. Finally, Benin Management CORP boosted its stake in Danaher Corporation by 1.1% in the first quarter. Benin Management CORP now owns 4,070 shares of the conglomerate’s stock worth $348,000 after buying an additional 45 shares during the period. 76.34% of the stock is owned by institutional investors.

Danaher Corporation (NYSE DHR) traded up 0.33% during trading on Friday, reaching $81.43. The company’s stock had a trading volume of 3,018,302 shares. The company has a 50 day moving average price of $84.11 and a 200-day moving average price of $84.25. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The company has a market capitalization of $56.57 billion, a PE ratio of 25.99 and a beta of 1.05.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.90 earnings per share. Equities research analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, June 30th were given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.69%. The ex-dividend date was Wednesday, June 28th. Danaher Corporation’s payout ratio is 17.83%.

WARNING: “Mirae Asset Global Investments Co. Ltd. Buys 15,201 Shares of Danaher Corporation (NYSE:DHR)” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/29/mirae-asset-global-investments-co-ltd-has-4-21-million-position-in-danaher-corporation-nysedhr-updated-updated-updated.html.

A number of research firms have recently commented on DHR. Wells Fargo & Company began coverage on Danaher Corporation in a research report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price objective for the company. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday. Citigroup Inc. set a $96.00 price target on Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Finally, BTIG Research reiterated a “buy” rating and set a $92.00 price target on shares of Danaher Corporation in a research report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $91.76.

In other Danaher Corporation news, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the transaction, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold 28,851 shares of company stock valued at $2,407,272 in the last three months. 12.20% of the stock is currently owned by company insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply